Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

(182,681) 266,291 83,610

Interest and other income

(expense), net (47,416) 13,663(g)(i) (33,753)

Income tax (benefit)

provision 1,550 10,247(j) 11,797

Equity earnings of

unconsolidated entities,

net of tax 2,666 336(b) 3,002

Net (loss) income $(228,981) $270,043 $41,062

Preferred stock dividends $- $-

Net (loss) income available

to common stockholders -

basic $(228,981) $41,062

Net (loss) income per

common share

Basic $(4.89) $0.88

Diluted $(4.89)(k) $0.84(m)

Weighted average common

shares - basic 46,787 46,787

Weighted average common

shares - diluted 46,787(k) 49,070(m)

(a) In calculating net income or loss on an adjusted cash basis, the

Company excludes from net income or loss (i) certain non-cash

charges, including amortization expense and stock-based compensation

expense, (ii) non-recurring charges and income, and (iii) certain

other charges and income that have a significant positive or

negative impact on results yet do not occur on a consistent or

regular basis in its business. In determining whether a particular

item meets one of these criteria, management considers facts and

circumstances that it believes are relevant. Management believes

that excluding such charges and income from income or loss allows

investors and management to evaluate and compare the Company's

operating results from continuing operations
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
(Date:1/22/2015)... Calif. , Jan. 22. 2015  Varian Medical Systems (NYSE: ... software, has been honored for its commitment to sustainability with ... companies. Varian is the highest ranked healthcare equipment company among ... today during the World Economic Forum at Davos, ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... December 23, 2014 “Preparative & ... HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, ... & Agriculture) - Forecasts to 2019” provides a ... opportunities, current market trends, and strategies impacting the ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... a certain through-the-looking-glass feel to them. We've heard a lot ... partners in IT. Often lost in that clamor is the ... you have before you can hope to improve it. Apparently, ... dating with marriage. You also don't want to confuse the ...
... world today are WWWno further explanation is required , ,There ... the alphabet, W, as in WWI or WWII, ... there's the WWF and WWF. The match between the World ... muscles losing to cuddly pandas, and the wrestlers became the ...
... MADISON, Wis. -- What's more important to a manufacturing company: ... Center for Quick Response Manufacturing , ruthlessly cutting down the ... seen as the best way to reduce costs and end ... ,"It's not usually about buying new equipment," Frank Rath, associate ...
Cached Biology Technology:Customers, clients and partners, oh my! 2Customers, clients and partners, oh my! 3The global power of WWW 2The global power of WWW 3University center offers speed boost to manufacturers 2
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... , Europe,s most prestigious innovation ... to present a video retrospective of the most exciting and innovative ... Toumazou and Sophie Wilson   A different ...   Starting on 22 January 2015 on   http://www.epo.org/european-inventor   ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
... Calif.- Children,s Hospital & Research Center Oakland is the ... technology that could revolutionize the way blood is analyzed ... similar to that used in some debit or credit ... a child,s blood sample. The procedure starts with ...
... This release is available in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2009-04/sfeb-roc042209.php,">Chinese ... Pennsylvania State University College of Medicine, Hershey, ... the Opioid Growth Factor (OGF, [Met5]-enkephalin), a ... nucleocytoplasmic translocation and reliant on the integrity ...
... at Wake Forest University School of Medicine while studying ... genetic predisposition to epilepsy can develop the disorder. ... Journal of Neuroscience , senior researcher Dwayne W. Godwin, ... report discovering that a gene, already known to predispose ...
Cached Biology News:Children's Hospital Oakland is first pediatric hospital to use 'laboratory-on-a-card' technology 2Regulation of cell proliferation by the OGF-OGFr axis is dependent on nuclear localization signals 2Regulation of cell proliferation by the OGF-OGFr axis is dependent on nuclear localization signals 3Researchers discover that gene switches on during development of epilepsy 2Researchers discover that gene switches on during development of epilepsy 3
... low form culture flask is designed for culturing organisms ... flask has a heavy beaded rim to protect against ... O.D. is 38mm and takes a No. 6.5 rubber ... a heat source smaller than the base of the ...
... be difficult to achieve in many bacterial ... or more restriction and modification (R-M) systems ... as "foreign". TypeOne™ Restriction Inhibitor provides a ... bacterial strains with type I R-M systems. ...
... The loxP-cm-loxP cassette ... in prokaryotic cells. The prokaryotic ... chloramphenicol resistance is a slightly modified ... mediates higher transcription efficiency than the ...
Includes a choice of any 3 EasySep mouse selection kits and EasySep magnet...
Biology Products: